ClinicalTrialsFinder

Measurable Residual Disease (MRD) Clinical Trials in Monterrey, Nuevo León

1 recruitingMonterrey, Nuevo León, Mexico

Showing 1–1 of 1 trials

Recruiting
Phase 2

Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL

Acute Lymphoblastic LeukemiaMeasurable Residual Disease (MRD)
Hospital Universitario Dr. Jose E. Gonzalez30 enrolled1 locationNCT06886074